Details for 2021175519

Up to date per 04.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON DURCH CFTR VERMITTELTE KRANKHEITEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021175519

EP Publication Number

3925607

E-Number

1582123

Language

PCT Number

Publication Date

22.12.2021 A

28.06.2023 B1

Registration Date

28.06.2023

AT Publication Date

15.07.2023

Application Date

14.04.2015

Registration Number

Priorities

15.04.2014

201461979848 P

03.10.2014

201462059287 P

IPC

A61K 31/404 20060101AFI20221201BHEP

Maximum Duration of Protection

14.04.2035

Owner

Vertex Pharmaceuticals Incorporated50 Northern Avenue Boston, MA 02210US

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

PHENIX, Brian Dean Acton 01720US

BAGNOL, Laurent Jean-claude Burlington 01803US

BRODEUR, Geoffrey Glen Boston 02210US

CHANDRAN, Sachin Somerville 02144US

DOKOU, Eleni Cambridge 02140US

FERRIS, Lori Ann Medford 02155US

KNEZIC, Dragutin Watertown 02472US

MCCARTY, Katie Lynn Watertown 02472US

MEDEK, Ales Winchester 01890US

WAGGENER, Sara A. N. Billerica 01862US

Information about Fees